Phase I/II study of enzastaurin (ENZ) plus temozolomide (TMZ) and radiation therapy (XRT) in patients with glioblastoma multiforme (GBM) or gliosarcoma (GS)

被引：2
|
作者：
Butowski, N. A.
Lamborn, K.
Chang, S.
Page, M.
Rabbitt, J.
Fedoroff, A.
Parvataneni, R.
Nicol, S. J.
Thornton, D.
Prados, M. D.
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.3559
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3559
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PHASE I STUDY OF AZD1775 WITH RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) AND EVALUATION OF INTRATUMORAL DRUG DISTRIBUTION (IDD) IN PATIENTS WITH RECURRENT GBM
    Alexander, Brian
    Supko, Jeffrey
    Agar, Nathalie
    Ahluwalia, Manmeet
    Desai, Arati
    Dietrich, Jorg
    Kaley, Thomas
    Peereboom, David
    Takebe, Naoko
    Desideri, Serena
    Fisher, Joy
    Sims, Megan
    Ye, Xiaobu
    Ligon, Keith
    Nabors, L. Burt
    Grossman, Stuart
    Wen, Patrick
    NEURO-ONCOLOGY, 2018, 20 : 13 - 14
  • [32] Phase I/II study of dianhydrogalactitol in patients with recurrent malignant glioblastoma multiforme (GBM).
    Shih, Kent C.
    Patel, Manish R.
    Butowski, Nicholas A.
    Bacha, Jeffrey A.
    Brown, Dennis
    Garner, William J.
    Stelno, Anne
    Schwartz, Richard Stephen
    Kanekal, Sarath
    Lopez, Lorena
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] Phase I study of ABT-414 mono- or combination therapy with temozolomide (TMZ) in recurrent glioblastoma (GBM)
    Gan, Hui K.
    Papadopoulos, Kyriakos P.
    Fichtel, Lisa
    Lassman, Andrew B.
    Merrell, Ryan
    Van Den Bent, Martin J.
    Kumthekar, Priya
    Scott, Andrew M.
    Pedersen, Michelle
    Gomez, Erica J.
    Fischer, Judee S.
    Ames, William
    Xiong, Hao
    Lee, Ho-Jin
    Munasinghe, Wijith
    Roberts-Rapp, Lisa
    Ansell, Peter
    Holen, Kyle D.
    Lai, Rose
    Reardon, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] PHASE I/II STUDY OF DIANHYDROGALACTITOL IN PATIENTS WITH RECURRENT MALIGNANT GLIOBLASTOMA MULTIFORME (GBM)
    Shih, Kent
    Patel, Manish
    Butowski, Nicholas
    Bacha, Jeffrey
    Brown, Dennis
    Garner, William
    Steino, Anne
    Schwartz, Richard
    Kanekal, Sarath
    Lopez, Lorena
    Burris, Howard A., III
    NEURO-ONCOLOGY, 2014, 16
  • [35] Phase 1 Study of Nelfinavir Concurrent With Temozolomide and Radiation Therapy in Patients With Glioblastoma Multiforme
    Fang, P.
    Alonso-Basanta, M.
    Maity, A.
    Hahn, S.
    Lustig, R.
    Dorsey, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S18 - S18
  • [36] Randomized phase II trial of erlotinib (E) versus temozolomide (TMZ) or BCNU in recurrent glioblastoma multiforme (GBM): EORTC 26034
    Van den Bent, Martin
    Brandes, Alba
    Rampling, Roy
    Kouwenhoven, Mathilde
    Kros, Johan M.
    Carpentier, Antoine
    Clement, Paul
    Klughammer, Barbara
    Bakker, Brenda
    Lacombe, Denis
    Gorlia, Thierry
    NEURO-ONCOLOGY, 2007, 9 (04) : 522 - 522
  • [37] Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme
    Jastaniyah, Noha
    Murtha, Albert
    Pervez, Nadeem
    Le, Duc
    Roa, Wilson
    Patel, Samir
    Mackenzie, Marc
    Fulton, Dorcas
    Field, Colin
    Ghosh, Sunita
    Fallone, Gino
    Abdulkarim, Bassam
    RADIATION ONCOLOGY, 2013, 8
  • [38] A PILOT PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (hypo-IMRT) COMBINED WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV) FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
    Ney, Douglas
    Carlson, Julie
    Damek, Denise
    Blatchford, Patrick
    Gaspar, Laurie
    Kavanagh, Brian
    Waziri, Allen
    Lillehei, Kevin
    Reddy, Krishna
    Chen, Changhu
    NEURO-ONCOLOGY, 2013, 15 : 80 - 81
  • [39] Randomized phase II trial of erlotinib (E) versus temozolomide (TMZ) or BCNU in recurrent glioblastoma multiforme (GBM): EORTC 26034
    Van Den Bent, M. J.
    Brandes, A.
    Rampling, R.
    Kouwenhoven, M.
    Kros, J. M.
    Carpentier, A. F.
    Clement, P.
    Klughammer, B.
    Gorlia, T.
    Lacombe, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme
    Noha Jastaniyah
    Albert Murtha
    Nadeem Pervez
    Duc Le
    Wilson Roa
    Samir Patel
    Marc Mackenzie
    Dorcas Fulton
    Colin Field
    Sunita Ghosh
    Gino Fallone
    Bassam Abdulkarim
    Radiation Oncology, 8
12345